Research location
Winterthur
Canton of Zurich, Switzerland
Advertisement
Research activity in Winterthur
Canton of Zurich, SwitzerlandCureCurrent currently publishes aggregate city-level research activity for this location: 21 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Winterthur
21 linked trials · page 1 of 1NEODOXy: Targeting Breast Cancer Stem Cells With DoxycyclineNCT06452394 · 2025-07-16 · 1 site observation
RECRUITING
Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?NCT06776731 · 2025-01-06 · 1 site observation
RECRUITING
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)NCT05017142 · 2020-04-14 · 1 site observation
RECRUITING
The SwissPrEPared StudyNCT03893188 · 2019-04-10 · 1 site observation
RECRUITING
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in SwitzerlandNCT03124212 · 2017-04-01 · 1 site observation
RECRUITING
Hyperoxia During Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?NCT06174207 · 2024-01-24 · 1 site observation
COMPLETED
The DIALOGUE Study: Swiss-Korean Billateral CollaborationNCT04214210 · 2022-04-15 · 1 site observation
COMPLETED
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerNCT05132582 · 2022-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast CancerNCT04752332 · 2021-05-10 · 1 site observation
TERMINATED
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)NCT03867084 · 2019-05-28 · 1 site observation
COMPLETED
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)NCT03644186 · 2019-04-16 · 1 site observation
COMPLETED
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)NCT03820986 · 2019-03-12 · 1 site observation
COMPLETED
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerNCT03539536 · 2018-10-10 · 1 site observation
ACTIVE_NOT_RECRUITING
Influence of a Food Supplement on the Gut Microbiome in Healthy Obese WomenNCT03223987 · 2017-05-11 · 1 site observation
COMPLETED
Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate CancerNCT03615131 · 2015-09-01 · 1 site observation
COMPLETED
Weight-loss Treatment Through Smartphone-assisted Dietary CoachingNCT02694614 · 2015-03-01 · 1 site observation
COMPLETED
Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot UlcerationNCT02086955 · 2013-02-01 · 1 site observation
UNKNOWN
Mobility Enhancing Nursing InterventionNCT02198599 · 2011-03-01 · 1 site observation
COMPLETED
Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized TrialNCT01770340 · 2011-01-01 · 1 site observation
TERMINATED
Management of Diabetes Mellitus Patients With RetinopathyNCT00828425 · 2008-12-01 · 1 site observation
COMPLETED
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyNCT00268476 · 2005-07-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.